title: Remarkable and persistent shrinkage of uterine leiomyoma associated with interferon alfa treatment for hepatitis.
authors.forename: K
authors.initials: K
authors.lastname: Minakuchi
authors.forename: N
authors.initials: N
authors.lastname: Kawamura
authors.forename: A
authors.initials: A
authors.lastname: Tsujimura
authors.forename: S
authors.initials: S
authors.lastname: Ogita
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007889:Leiomyoma / Q000150:complications / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha